Unlocking Approval: Chris Gasink from Johnson & Johnson in an Enlightening Conversation with PharmaShots

Shots: Johnson & Johnson’s (J&J) Tremfya recently received its third approval from the US FDA, supported by the pivotal QUASAR study, which demonstrated significant remission after one year of treatment in adults with moderately to severely active ulcerative colitis Tremfya is a dual-binding monoclonal antibody targeting interleukin 23 (IL-23), a cytokine responsible for inflammation At…

BySaurabh ChaubeyFebruary 3, 2025

THOUGHTSPOT

The Role of CCL17 in Immune Regulation: Unlocking New Therapeutic Possibilities

The CCL17 gene, a key player in the human immune system, has garnered significant attention for its role in disease regulation. This chemokine gene is pivotal in mediating immune responses, acting as a messenger that guides immune cells to sites of inflammation. Understanding its function and regulation is essential for unraveling the complexities of immune-related…

ByYan LiaoNovember 8, 2024

THOUGHTSPOT

Managing Toothache With OTC Medications: What You Need To Know

Toothaches can be incredibly disruptive, often turning simple tasks into painful challenges. Whether it's a dull, throbbing pain or a sharp, stabbing sensation, the discomfort can make it difficult to eat, sleep, or even concentrate on your daily activities. While it's always best to consult a dentist for persistent or severe tooth pain, over-the-counter (OTC)…

BySophie MillerSeptember 20, 2024

INSIGHTS+

Disease of the Month – Ulcerative Colitis

Shots: To keep our readers acquainted with several disease conditions, ongoing trials, and available treatment options, PharmaShots brings every month a detailed take on a particular disease after thorough research Continuing the series for the disease of the month, PharmaShots presents a condensed report on Ulcerative Colitis, which causes inflammation and sores (ulcers) in the digestive…

BySenior EditorNovember 28, 2023

TOP 20

Top 20 Immunology Companies Based on 2022 Immunology Segment Total Revenue

Shots: With the noble responsibility of ensuring a healthy society on their shoulders, biopharma companies focused on Immunology are diligently working to develop treatments, vaccines, antibodies, and drugs The global Immunology market was valued at $97.93B in 2021 and is anticipated to reach $184.21B by 2029 with a CAGR of 8.5 percent. In 2022, AbbVie…

ByPrince GiriAugust 14, 2023

VIEWPOINTS

Jason Winnike, Study Director at Metabolon Shares Insights from the Launch of its Oxysterol Targeted Panel

Shots: Jason shared his views on the launch of Metabolon, Inc.’s new Oxysterols Targeted Panel, highlighting its key features He told how the panel measures 12 oxysterols and related sterols of biological significance to identify biomarkers for the prediction and early detection of cardiovascular diseases, neurodegenerative diseases, and cancer The interview gives a profound understanding…

BySenior EditorMarch 6, 2023

VIEWPOINTS

PharmaShots Interview: 180 Life Sciences’ Dr. Jim Woody Shares Insight on Repurposing Anti-TNF to Meet Unmet Needs in Pain and Inflammation

In an interview with PharmaShots, Dr. Jim Woody, MD, Ph.D., Chief Executive Officer at 180 Life Sciences shared his insights on the Phase 2b study of anti-TNF for the treatment of the early Dupuytren's disease. Shots: 180 Life Sciences used anti-TNF to treat early Dupuytren’s disease and the Phase 2b study is complete. Additional programs using anti-TNF soon to…

BySenior EditorFebruary 15, 2022

Unlocking Approval: Chris Gasink from Johnson & Johnson in an Enlightening Conversation with PharmaShots

The Role of CCL17 in Immune Regulation: Unlocking New Therapeutic Possibilities

Managing Toothache With OTC Medications: What You Need To Know

Disease of the Month – Ulcerative Colitis

Top 20 Immunology Companies Based on 2022 Immunology Segment Total Revenue

Jason Winnike, Study Director at Metabolon Shares Insights from the Launch of its Oxysterol Targeted Panel

PharmaShots Interview: 180 Life Sciences’ Dr. Jim Woody Shares Insight on Repurposing Anti-TNF to Meet Unmet Needs in Pain and Inflammation

Contact US

OUR INFORMATION

FOLLW US

Unlocking Approval: Chris Gasink from Johnson & Johnson in an Enlightening Conversation with PharmaShots

The Role of CCL17 in Immune Regulation: Unlocking New Therapeutic Possibilities

Managing Toothache With OTC Medications: What You Need To Know

Disease of the Month – Ulcerative Colitis

Top 20 Immunology Companies Based on 2022 Immunology Segment Total Revenue

Jason Winnike, Study Director at Metabolon Shares Insights from the Launch of its Oxysterol Targeted Panel

PharmaShots Interview: 180 Life Sciences’ Dr. Jim Woody Shares Insight on Repurposing Anti-TNF to Meet Unmet Needs in Pain and Inflammation

FOLLW US

Sign Up to Our Newsletter